The Gross Margin of Epigenomics AG (ECX.DE) is 75.26%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2022-12-31 | 75.26% |
| 2021-12-31 | 97.81% |
| 2020-12-31 | 82.78% |